REQUEST A DEMO
Total
USD $0.00
Search more companies

Beihai Gofar Chuanshan Biological Co., Ltd. (China)

Main Activities: Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing | Pharmaceutical and Medicine Manufacturing
Secondary Activities: Accommodation
Full name: Beihai Gofar Chuanshan Biological Co., Ltd. Profile Updated: November 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Beihai Gofar Chuanshan Biological Co., Ltd. is a publicly listed company on the Shanghai Stock Exchange. It is the only company in China engaged in the comprehensive development and processing of marine pearl shellfish (Hepu South Pearl), algae, and crustaceans. The company is recognized as a national demonstration enterprise in the agricultural processing industry and a designated production enterprise for special needs products for ethnic minorities. It is also a high-tech enterprise recognized by the Ministry of Science and Technology and the Guangxi Zhuang Autonomous Region. Additionally, it is a key leading enterprise in the agricultural industrialization of Guangxi Zhuang Autonomous Region and a pilot enterprise for patent work. The company's main business includes pesticide manufacturing, pharmaceuticals, pharmaceutical commerce, and hotel services. Its subsidiaries are mainly located in Guangxi and Hunan provinces, establishing a nationwide marketing network and regional product and service brands. The company aims to utilize the abundant marine resources in the Beibu Gulf to develop environmentally friendly products such as biopharmaceuticals, biopesticides, and seaweed liquid fertilizers that cater to both domestic and international markets. It strives to become a leading enterprise in Guangxi and a key national enterprise in the circular economy. On June 3, 2021, the company changed its Chinese name from "Beihai Guofa Marine Biotechnology Co., Ltd." to "Beihai Guofa Chuanshan Biological Co., Ltd."

Headquarters
No. 3, Beibuwan Middle Road, Haicheng District, Beihai City, Guangxi Zhuang Autonomous Region
Beihai; Guangxi; Postal Code: 536000

Contact Details: Purchase the Beihai Gofar Chuanshan Biological Co., Ltd. report to view the information.

Website: http://www.gofar.com.cn

Basic Information
Total Employees:
Purchase the Beihai Gofar Chuanshan Biological Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Beihai Gofar Chuanshan Biological Co., Ltd. report to view the information.
Registered Capital:
Purchase the Beihai Gofar Chuanshan Biological Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Beihai Gofar Chuanshan Biological Co., Ltd. report to view the information.
Incorporation Date:
January 22, 1993
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
13.24%
Purchase this report to view the information.
3.69%
Purchase this report to view the information.
2.66%
Purchase this report to view the information.
2.35%
Purchase this report to view the information.
1.9%
Subsidiaries
Beihai Guofa Marine Biological Pesticide Co., Ltd.
Beihai Guofa Pharmaceutical Co., Ltd.
Beijing Xiangya Medical Technology Co., Ltd.
Company Performance
Financial values in the chart are available after Beihai Gofar Chuanshan Biological Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-6.99%
Total operating revenue
-6.38%
Operating profit (EBIT)
-19.39%
Net Profit (Loss) for the Period
-34.89%
Total assets
-9.55%
Total equity
-9.11%
Operating Profit Margin (ROS)
-1.35%
Net Profit Margin
-2.27%
Return on Equity (ROE)
-0.74%
Debt to Equity Ratio
0.34%
Quick Ratio
0.32%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?